| 000 | 02901nam a22005175i 4500 | ||
|---|---|---|---|
| 001 | 978-1-4614-0379-1 | ||
| 003 | DE-He213 | ||
| 005 | 20140220083238.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 110916s2012 xxu| s |||| 0|eng d | ||
| 020 |
_a9781461403791 _9978-1-4614-0379-1 |
||
| 024 | 7 |
_a10.1007/978-1-4614-0379-1 _2doi |
|
| 050 | 4 | _aTP248.13-248.65 | |
| 072 | 7 |
_aTCB _2bicssc |
|
| 072 | 7 |
_aSCI010000 _2bisacsh |
|
| 082 | 0 | 4 |
_a660.6 _223 |
| 100 | 1 |
_aMatijević, Egon. _eeditor. |
|
| 245 | 1 | 0 |
_aFine Particles in Medicine and Pharmacy _h[electronic resource] / _cedited by Egon Matijević. |
| 264 | 1 |
_aBoston, MA : _bSpringer US : _bImprint: Springer, _c2012. |
|
| 300 |
_aXIII, 348p. 168 illus., 74 illus. in color. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 505 | 0 | _aModels of Size and Shape Control in Synthesis of Uniform Colloids and Nanocrystals -- Preparation of Uniform Drug Particles -- Biomedical Applications of Metal Oxides -- Biomedical Applications of Gold Nanoparticles -- Biomedical Applications of Magnetic Particles -- Degradable Polymer Particles for Biomedical Applications -- Functionalization of Inorganic Nanoparticles for Targeted Delivery -- Particle Deposition in the Human Respiratory Tract -- Detection of Oxidative Stress Biomarkers Using Functional Gold -- Stimuli-responsive Thin Films and Capsules: Approaching Smart Drug Delivery Systems -- Medicine in Reverse: Colloidal Technology for Combating Chemical Overdoses. | |
| 520 | _aPharmaceutical manufacture is very exacting – for example, drugs must be uniform in size, shape, efficacy, bioavailability, and safety. The presence of different polymorphs in drug production is a serious problem, since different polymorphs differ in bioavailability, solubility, dissolution rate, chemical and physical stability, melting point, color, filterability, density, and flow properties. Fine Particles in Medicine and Pharmacy discusses particle size, shape, and composition and how they determine the choice of polymorph of a drug. | ||
| 650 | 0 | _aChemistry. | |
| 650 | 0 | _aAnalytical biochemistry. | |
| 650 | 0 | _aBiotechnology. | |
| 650 | 0 | _aChemical engineering. | |
| 650 | 0 | _aBiochemistry. | |
| 650 | 0 | _aPharmacy. | |
| 650 | 1 | 4 | _aChemistry. |
| 650 | 2 | 4 | _aBiotechnology. |
| 650 | 2 | 4 | _aMedicinal Chemistry. |
| 650 | 2 | 4 | _aIndustrial Chemistry/Chemical Engineering. |
| 650 | 2 | 4 | _aSurface and Interface Science, Thin Films. |
| 650 | 2 | 4 | _aPharmacy. |
| 650 | 2 | 4 | _aAnalytical Chemistry. |
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9781461403784 |
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/978-1-4614-0379-1 |
| 912 | _aZDB-2-CMS | ||
| 999 |
_c100840 _d100840 |
||